Exelixis, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
EXEL
Exelixis, INCForm 4: Exelixis Director Sells Shares
Mary C Beckerle, a Director of Exelixis, Inc., sold 9,812 shares of common stock on August 10, 2026 for $53.66 per share.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. Director Jack Wyszomierski sold 3,925 shares of common stock pursuant to a pre-established Rule 10b5-1 trading plan.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. Director Sue Gail Eckhardt sold 9,812 shares of common stock pursuant to a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
EXEL
Exelixis, INCDirector Stelios Papadopoulos was granted 8,367 restricted stock units as part of the Exelixis, Inc. 2017 Equity Incentive Plan.
NASDAQ
EXEL
Exelixis, INCDirector Tomas J. Heyman was granted 8,367 restricted stock units as part of the Exelixis, Inc. 2017 Equity Incentive Plan.
NASDAQ
EXEL
Exelixis, INCDirector Sue Gail Eckhardt was granted 8,367 restricted stock units by Exelixis, Inc. on May 27, 2026.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. director Julie Smith was granted 8,367 restricted stock units as part of the company's 2017 Equity Incentive Plan.
NASDAQ
EXEL
Exelixis, INCDirector Maria C. Freire was granted 8,367 restricted stock units as part of the Exelixis, Inc. 2017 Equity Incentive Plan.
NASDAQ
EXEL
Exelixis, INCDirector Mary C. Beckerle was granted 8,367 restricted stock units as part of the Exelixis, Inc. 2017 Equity Incentive Plan.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. director Bob Oliver was granted 8,367 restricted stock units as part of the company's 2017 Equity Incentive Plan.
NASDAQ
EXEL
Exelixis, INCDirector Jack L. Wyszomierski was granted 8,367 restricted stock units as part of the Exelixis, Inc. 2017 Equity Incentive Plan.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. director George Poste was granted 8,367 restricted stock units as part of the company's 2017 Equity Incentive Plan.
NASDAQ
EXEL
Exelixis, INCDirector David Johnson and Caligan Partners LP were granted 19,133 stock options in Exelixis, Inc. as part of an equity incentive plan.
NASDAQ
EXEL
Exelixis, INCDana Aftab, EVP of Research and Development at Exelixis, Inc., sold 43,451 shares of common stock on May 26, 2026.
NASDAQ
EXEL
Exelixis, INCExelixis EVP of Commercial Patrick J. Haley sold 32,110 shares of common stock at an average price of $49.81.
NASDAQ
EXEL
Exelixis, INCExelixis CEO Michael Morrissey disclosed tax-related share withholding and a transfer of shares to a family trust.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. EVP and CFO Christopher J. Senner reported the sale of 34,901 shares and the withholding of 40,892 shares for tax obligations.
NASDAQ
EXEL
Exelixis, INCEVP of Commercial Patrick J. Haley reported the withholding of 33,265 shares to satisfy tax obligations related to RSU vesting.
NASDAQ
EXEL
Exelixis, INCSVP and General Counsel Brenda Hefti sold 6,625 shares of Exelixis common stock under a pre-established Rule 10b5-1 trading plan.
NASDAQ
EXEL
Exelixis, INCEVP of Research and Development Dana Aftab reported the withholding of 30,578 shares to satisfy tax obligations related to RSU vesting.
NASDAQ
EXEL
Exelixis, INCDirector Mary C. Beckerle exercised stock options and sold shares of Exelixis, Inc. common stock on May 7, 2026.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. Director Maria C. Freire exercised options for 20,634 shares and subsequently sold them on May 7, 2026.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. Director George Poste sold 60,000 shares of common stock at a weighted average price of $45.71.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. CEO Michael Morrissey reported a gift of 109,676 shares of common stock to the Bombora Rise Foundation.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc.'s EVP of Research and Development, Dana Aftab, was granted 52,018 restricted stock units on February 26, 2026.
NASDAQ
EXEL
Exelixis, INCExelixis's EVP and CFO, Christopher J. Senner, reported the acquisition of 52,018 shares of common stock through a restricted stock unit grant.
NASDAQ
EXEL
Exelixis, INCExelixis' SVP and General Counsel, Brenda Hefti, was granted 23,119 restricted stock units on February 26, 2026, as part of the company's equity incentive plan.
NASDAQ
EXEL
Exelixis, INCExelixis, Inc. EVP, Commercial Patrick J. Haley was granted 40,459 restricted stock units, vesting over several years.
NASDAQ
EXEL
Exelixis, INCExelixis President and CEO Michael Morrissey reported a gift of 100,278 shares and the grant of 160,437 restricted stock units.
NASDAQ
EXEL
Exelixis, INCExelixis EVP of Research and Development, Dana Aftab, sold 47,918 shares of common stock for $44.5 per share in a pre-scheduled transaction.